nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCG2—Ezetimibe—atherosclerosis	0.0684	0.087	CbGbCtD
Apixaban—ABCG2—Rosuvastatin—atherosclerosis	0.0684	0.087	CbGbCtD
Apixaban—ABCG2—Pravastatin—atherosclerosis	0.0622	0.0792	CbGbCtD
Apixaban—CYP3A5—Rosuvastatin—atherosclerosis	0.0379	0.0482	CbGbCtD
Apixaban—CYP3A5—Simvastatin—atherosclerosis	0.0352	0.0448	CbGbCtD
Apixaban—CYP3A5—Pravastatin—atherosclerosis	0.0345	0.0439	CbGbCtD
Apixaban—CYP3A5—Lovastatin—atherosclerosis	0.0345	0.0439	CbGbCtD
Apixaban—CYP2C8—Simvastatin—atherosclerosis	0.0339	0.0431	CbGbCtD
Apixaban—CYP2C8—Pravastatin—atherosclerosis	0.0331	0.0422	CbGbCtD
Apixaban—CYP2C8—Lovastatin—atherosclerosis	0.0331	0.0422	CbGbCtD
Apixaban—CYP2C19—Rosuvastatin—atherosclerosis	0.0306	0.0389	CbGbCtD
Apixaban—CYP2C19—Simvastatin—atherosclerosis	0.0284	0.0362	CbGbCtD
Apixaban—CYP2C19—Lovastatin—atherosclerosis	0.0278	0.0354	CbGbCtD
Apixaban—CYP2C9—Rosuvastatin—atherosclerosis	0.0254	0.0323	CbGbCtD
Apixaban—ABCB1—Ezetimibe—atherosclerosis	0.0247	0.0314	CbGbCtD
Apixaban—CYP2C9—Simvastatin—atherosclerosis	0.0236	0.0301	CbGbCtD
Apixaban—CYP2C9—Lovastatin—atherosclerosis	0.0231	0.0294	CbGbCtD
Apixaban—CYP2C9—Pravastatin—atherosclerosis	0.0231	0.0294	CbGbCtD
Apixaban—ABCB1—Simvastatin—atherosclerosis	0.0229	0.0292	CbGbCtD
Apixaban—ABCB1—Pravastatin—atherosclerosis	0.0224	0.0285	CbGbCtD
Apixaban—ABCB1—Lovastatin—atherosclerosis	0.0224	0.0285	CbGbCtD
Apixaban—CYP3A4—Ezetimibe—atherosclerosis	0.0148	0.0188	CbGbCtD
Apixaban—CYP3A4—Rosuvastatin—atherosclerosis	0.0148	0.0188	CbGbCtD
Apixaban—CYP3A4—Simvastatin—atherosclerosis	0.0137	0.0175	CbGbCtD
Apixaban—CYP3A4—Pravastatin—atherosclerosis	0.0134	0.0171	CbGbCtD
Apixaban—CYP3A4—Lovastatin—atherosclerosis	0.0134	0.0171	CbGbCtD
Apixaban—Transaminases increased—Lovastatin—atherosclerosis	0.00225	0.0396	CcSEcCtD
Apixaban—Transaminases increased—Ezetimibe—atherosclerosis	0.00221	0.0389	CcSEcCtD
Apixaban—Transaminases increased—Simvastatin—atherosclerosis	0.00211	0.0371	CcSEcCtD
Apixaban—Transaminases increased—Pravastatin—atherosclerosis	0.00191	0.0335	CcSEcCtD
Apixaban—Gamma-glutamyltransferase increased—Ezetimibe—atherosclerosis	0.00163	0.0287	CcSEcCtD
Apixaban—Haemoptysis—Niacin—atherosclerosis	0.00159	0.028	CcSEcCtD
Apixaban—Gamma-glutamyltransferase increased—Pravastatin—atherosclerosis	0.00141	0.0248	CcSEcCtD
Apixaban—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.00135	0.0237	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.00114	0.0201	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.00112	0.0197	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.00107	0.0188	CcSEcCtD
Apixaban—Diabetes mellitus—Simvastatin—atherosclerosis	0.00107	0.0188	CcSEcCtD
Apixaban—Breast disorder—Rosuvastatin—atherosclerosis	0.00106	0.0187	CcSEcCtD
Apixaban—CYP2J2—artery—atherosclerosis	0.00103	0.217	CbGeAlD
Apixaban—Diabetes mellitus—Niacin—atherosclerosis	0.000983	0.0173	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.000968	0.017	CcSEcCtD
Apixaban—Liver function test abnormal—Ezetimibe—atherosclerosis	0.000901	0.0158	CcSEcCtD
Apixaban—Breast disorder—Ezetimibe—atherosclerosis	0.000882	0.0155	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.000879	0.0155	CcSEcCtD
Apixaban—Haematuria—Rosuvastatin—atherosclerosis	0.000863	0.0152	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.000861	0.0151	CcSEcCtD
Apixaban—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.000856	0.015	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.000855	0.015	CcSEcCtD
Apixaban—CYP2J2—blood vessel—atherosclerosis	0.000803	0.169	CbGeAlD
Apixaban—Liver function test abnormal—Niacin—atherosclerosis	0.000789	0.0139	CcSEcCtD
Apixaban—Liver function test abnormal—Pravastatin—atherosclerosis	0.000777	0.0137	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000742	0.013	CcSEcCtD
Apixaban—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000712	0.0125	CcSEcCtD
Apixaban—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000664	0.0117	CcSEcCtD
Apixaban—Angiopathy—Ezetimibe—atherosclerosis	0.000613	0.0108	CcSEcCtD
Apixaban—Immune system disorder—Ezetimibe—atherosclerosis	0.00061	0.0107	CcSEcCtD
Apixaban—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000609	0.0107	CcSEcCtD
Apixaban—Haemoglobin—Niacin—atherosclerosis	0.000594	0.0104	CcSEcCtD
Apixaban—Haemorrhage—Niacin—atherosclerosis	0.000591	0.0104	CcSEcCtD
Apixaban—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000566	0.00995	CcSEcCtD
Apixaban—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000565	0.00993	CcSEcCtD
Apixaban—Eye disorder—Niacin—atherosclerosis	0.000553	0.00971	CcSEcCtD
Apixaban—Anaemia—Ezetimibe—atherosclerosis	0.000543	0.00955	CcSEcCtD
Apixaban—Angiopathy—Niacin—atherosclerosis	0.000537	0.00943	CcSEcCtD
Apixaban—Anaemia—Simvastatin—atherosclerosis	0.000518	0.00911	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000497	0.00874	CcSEcCtD
Apixaban—Anaphylactic shock—Lovastatin—atherosclerosis	0.000489	0.0086	CcSEcCtD
Apixaban—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00048	0.00843	CcSEcCtD
Apixaban—Thrombocytopenia—Lovastatin—atherosclerosis	0.000479	0.00842	CcSEcCtD
Apixaban—Nervous system disorder—Ezetimibe—atherosclerosis	0.000471	0.00827	CcSEcCtD
Apixaban—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00047	0.00826	CcSEcCtD
Apixaban—Anaemia—Pravastatin—atherosclerosis	0.000469	0.00824	CcSEcCtD
Apixaban—Skin disorder—Ezetimibe—atherosclerosis	0.000466	0.00819	CcSEcCtD
Apixaban—Syncope—Niacin—atherosclerosis	0.000462	0.00812	CcSEcCtD
Apixaban—Anaphylactic shock—Simvastatin—atherosclerosis	0.000458	0.00804	CcSEcCtD
Apixaban—Loss of consciousness—Niacin—atherosclerosis	0.000453	0.00795	CcSEcCtD
Apixaban—Thrombocytopenia—Simvastatin—atherosclerosis	0.000448	0.00788	CcSEcCtD
Apixaban—F10—cardiovascular system—atherosclerosis	0.000437	0.0922	CbGeAlD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000435	0.00765	CcSEcCtD
Apixaban—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000425	0.00748	CcSEcCtD
Apixaban—Anaphylactic shock—Niacin—atherosclerosis	0.00042	0.00739	CcSEcCtD
Apixaban—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000414	0.00728	CcSEcCtD
Apixaban—Anaphylactic shock—Pravastatin—atherosclerosis	0.000414	0.00727	CcSEcCtD
Apixaban—Shock—Niacin—atherosclerosis	0.000413	0.00727	CcSEcCtD
Apixaban—Skin disorder—Niacin—atherosclerosis	0.000408	0.00717	CcSEcCtD
Apixaban—Thrombocytopenia—Pravastatin—atherosclerosis	0.000405	0.00712	CcSEcCtD
Apixaban—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000395	0.00694	CcSEcCtD
Apixaban—Hypotension—Niacin—atherosclerosis	0.000393	0.0069	CcSEcCtD
Apixaban—F10—adipose tissue—atherosclerosis	0.000386	0.0813	CbGeAlD
Apixaban—Dizziness—Rosuvastatin—atherosclerosis	0.000382	0.00671	CcSEcCtD
Apixaban—Rash—Rosuvastatin—atherosclerosis	0.000364	0.0064	CcSEcCtD
Apixaban—Dermatitis—Rosuvastatin—atherosclerosis	0.000364	0.00639	CcSEcCtD
Apixaban—Gastrointestinal disorder—Niacin—atherosclerosis	0.000363	0.00638	CcSEcCtD
Apixaban—Hypersensitivity—Lovastatin—atherosclerosis	0.00036	0.00634	CcSEcCtD
Apixaban—CYP2J2—cardiovascular system—atherosclerosis	0.000358	0.0755	CbGeAlD
Apixaban—Hypersensitivity—Ezetimibe—atherosclerosis	0.000354	0.00621	CcSEcCtD
Apixaban—Nausea—Rosuvastatin—atherosclerosis	0.000343	0.00603	CcSEcCtD
Apixaban—Hypersensitivity—Simvastatin—atherosclerosis	0.000337	0.00593	CcSEcCtD
Apixaban—Dizziness—Lovastatin—atherosclerosis	0.000324	0.00569	CcSEcCtD
Apixaban—Dizziness—Ezetimibe—atherosclerosis	0.000317	0.00558	CcSEcCtD
Apixaban—Hypersensitivity—Niacin—atherosclerosis	0.00031	0.00544	CcSEcCtD
Apixaban—Rash—Lovastatin—atherosclerosis	0.000308	0.00542	CcSEcCtD
Apixaban—Dermatitis—Lovastatin—atherosclerosis	0.000308	0.00542	CcSEcCtD
Apixaban—Hypersensitivity—Pravastatin—atherosclerosis	0.000305	0.00536	CcSEcCtD
Apixaban—Dizziness—Simvastatin—atherosclerosis	0.000303	0.00532	CcSEcCtD
Apixaban—Rash—Ezetimibe—atherosclerosis	0.000303	0.00532	CcSEcCtD
Apixaban—Dermatitis—Ezetimibe—atherosclerosis	0.000302	0.00531	CcSEcCtD
Apixaban—Nausea—Lovastatin—atherosclerosis	0.000291	0.00511	CcSEcCtD
Apixaban—Rash—Simvastatin—atherosclerosis	0.000289	0.00507	CcSEcCtD
Apixaban—Dermatitis—Simvastatin—atherosclerosis	0.000288	0.00507	CcSEcCtD
Apixaban—Nausea—Ezetimibe—atherosclerosis	0.000285	0.00501	CcSEcCtD
Apixaban—Dizziness—Niacin—atherosclerosis	0.000278	0.00488	CcSEcCtD
Apixaban—Dizziness—Pravastatin—atherosclerosis	0.000274	0.00481	CcSEcCtD
Apixaban—Nausea—Simvastatin—atherosclerosis	0.000272	0.00478	CcSEcCtD
Apixaban—F10—liver—atherosclerosis	0.00027	0.057	CbGeAlD
Apixaban—Rash—Niacin—atherosclerosis	0.000265	0.00466	CcSEcCtD
Apixaban—Dermatitis—Niacin—atherosclerosis	0.000265	0.00465	CcSEcCtD
Apixaban—Rash—Pravastatin—atherosclerosis	0.000261	0.00458	CcSEcCtD
Apixaban—Dermatitis—Pravastatin—atherosclerosis	0.000261	0.00458	CcSEcCtD
Apixaban—Nausea—Niacin—atherosclerosis	0.00025	0.00439	CcSEcCtD
Apixaban—Nausea—Pravastatin—atherosclerosis	0.000246	0.00432	CcSEcCtD
Apixaban—CYP2J2—liver—atherosclerosis	0.000222	0.0467	CbGeAlD
Apixaban—ABCB1—blood vessel—atherosclerosis	0.00015	0.0317	CbGeAlD
Apixaban—CYP2C9—cardiovascular system—atherosclerosis	0.000124	0.0262	CbGeAlD
Apixaban—ABCG2—adipose tissue—atherosclerosis	0.00012	0.0253	CbGeAlD
Apixaban—CYP3A5—adipose tissue—atherosclerosis	0.000111	0.0234	CbGeAlD
Apixaban—CYP2C19—liver—atherosclerosis	9.9e-05	0.0209	CbGeAlD
Apixaban—CYP2C8—liver—atherosclerosis	8.64e-05	0.0182	CbGeAlD
Apixaban—ABCG2—liver—atherosclerosis	8.4e-05	0.0177	CbGeAlD
Apixaban—CYP1A2—liver—atherosclerosis	8.09e-05	0.017	CbGeAlD
Apixaban—CYP3A5—liver—atherosclerosis	7.8e-05	0.0164	CbGeAlD
Apixaban—CYP2C9—liver—atherosclerosis	7.68e-05	0.0162	CbGeAlD
Apixaban—ABCB1—cardiovascular system—atherosclerosis	6.7e-05	0.0141	CbGeAlD
Apixaban—ABCB1—adipose tissue—atherosclerosis	5.91e-05	0.0125	CbGeAlD
Apixaban—CYP3A4—liver—atherosclerosis	5.85e-05	0.0123	CbGeAlD
Apixaban—ABCB1—liver—atherosclerosis	4.14e-05	0.00873	CbGeAlD
Apixaban—ABCG2—Metabolism—GPX1—atherosclerosis	1.2e-05	7.87e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.19e-05	7.83e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.19e-05	7.82e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.18e-05	7.76e-05	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.18e-05	7.72e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.17e-05	7.67e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CD36—atherosclerosis	1.17e-05	7.66e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.16e-05	7.63e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.16e-05	7.6e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.16e-05	7.59e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.16e-05	7.58e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—SCARB1—atherosclerosis	1.16e-05	7.58e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.15e-05	7.53e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOA2—atherosclerosis	1.15e-05	7.53e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.15e-05	7.53e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.15e-05	7.53e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.14e-05	7.49e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.13e-05	7.44e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.13e-05	7.43e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.13e-05	7.38e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.12e-05	7.37e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.12e-05	7.36e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.12e-05	7.32e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—LIPC—atherosclerosis	1.12e-05	7.32e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.12e-05	7.31e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—APOC3—atherosclerosis	1.11e-05	7.28e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—MTHFR—atherosclerosis	1.11e-05	7.26e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—LDLR—atherosclerosis	1.1e-05	7.23e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NAMPT—atherosclerosis	1.1e-05	7.19e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—LPA—atherosclerosis	1.1e-05	7.18e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.09e-05	7.16e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—LIPC—atherosclerosis	1.09e-05	7.15e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PPARA—atherosclerosis	1.09e-05	7.12e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—APOC3—atherosclerosis	1.08e-05	7.1e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CETP—atherosclerosis	1.08e-05	7.06e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—LDLR—atherosclerosis	1.08e-05	7.06e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—BGN—atherosclerosis	1.06e-05	6.95e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.06e-05	6.92e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.05e-05	6.91e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—AGT—atherosclerosis	1.05e-05	6.9e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CETP—atherosclerosis	1.05e-05	6.89e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOA5—atherosclerosis	1.05e-05	6.88e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—FABP4—atherosclerosis	1.05e-05	6.88e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—LCAT—atherosclerosis	1.05e-05	6.88e-05	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.03e-05	6.77e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.03e-05	6.76e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—APOE—atherosclerosis	1.03e-05	6.76e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOA4—atherosclerosis	1.03e-05	6.75e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.03e-05	6.72e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CAV1—atherosclerosis	1.02e-05	6.7e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.02e-05	6.69e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—APOA1—atherosclerosis	1.02e-05	6.68e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.02e-05	6.68e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—LIPC—atherosclerosis	1.02e-05	6.68e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—APOC3—atherosclerosis	1.01e-05	6.63e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.01e-05	6.63e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.01e-05	6.63e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SCARB1—atherosclerosis	1.01e-05	6.6e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—LDLR—atherosclerosis	1.01e-05	6.59e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.01e-05	6.59e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1e-05	6.55e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	9.91e-06	6.49e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	9.89e-06	6.48e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.85e-06	6.46e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CETP—atherosclerosis	9.83e-06	6.44e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALOX5—atherosclerosis	9.77e-06	6.4e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—HMGCR—atherosclerosis	9.75e-06	6.39e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ABCA1—atherosclerosis	9.74e-06	6.38e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—HMOX1—atherosclerosis	9.64e-06	6.32e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—HMGCR—atherosclerosis	9.52e-06	6.24e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SCARB1—atherosclerosis	9.41e-06	6.17e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP27A1—atherosclerosis	9.35e-06	6.13e-05	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	9.33e-06	6.11e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CG—atherosclerosis	9.31e-06	6.1e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—APOB—atherosclerosis	9.24e-06	6.05e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.17e-06	6.01e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	9.03e-06	5.91e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PPARG—atherosclerosis	8.99e-06	5.89e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTM1—atherosclerosis	8.99e-06	5.89e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HMGCR—atherosclerosis	8.89e-06	5.82e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOA2—atherosclerosis	8.87e-06	5.81e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALOX15—atherosclerosis	8.87e-06	5.81e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	8.87e-06	5.81e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	8.87e-06	5.81e-05	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—AKT1—atherosclerosis	8.83e-06	5.79e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—LPL—atherosclerosis	8.82e-06	5.78e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—INS—atherosclerosis	8.82e-06	5.78e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.79e-06	5.76e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NAMPT—atherosclerosis	8.76e-06	5.74e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCG5—atherosclerosis	8.76e-06	5.74e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.71e-06	5.71e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—LIPC—atherosclerosis	8.71e-06	5.7e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ABCA1—atherosclerosis	8.69e-06	5.69e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOC3—atherosclerosis	8.65e-06	5.67e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GPX1—atherosclerosis	8.61e-06	5.64e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—LDLR—atherosclerosis	8.6e-06	5.64e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ABCA1—atherosclerosis	8.48e-06	5.56e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—LPA—atherosclerosis	8.46e-06	5.54e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CETP—atherosclerosis	8.4e-06	5.5e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CD36—atherosclerosis	8.38e-06	5.49e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—HMOX1—atherosclerosis	8.35e-06	5.47e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—BGN—atherosclerosis	8.19e-06	5.37e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOA5—atherosclerosis	8.11e-06	5.31e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ALB—atherosclerosis	8.08e-06	5.3e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SCARB1—atherosclerosis	8.04e-06	5.27e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.02e-06	5.25e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—APOB—atherosclerosis	8e-06	5.24e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—MTHFR—atherosclerosis	7.94e-06	5.2e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ABCA1—atherosclerosis	7.92e-06	5.19e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.83e-06	5.13e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	7.81e-06	5.11e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPARA—atherosclerosis	7.79e-06	5.1e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTM1—atherosclerosis	7.78e-06	5.1e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—NOS3—atherosclerosis	7.73e-06	5.07e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—LPL—atherosclerosis	7.64e-06	5.01e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HMGCR—atherosclerosis	7.6e-06	4.98e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AGT—atherosclerosis	7.55e-06	4.94e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALOX5—atherosclerosis	7.54e-06	4.94e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—HMOX1—atherosclerosis	7.46e-06	4.89e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GPX1—atherosclerosis	7.45e-06	4.88e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—APOE—atherosclerosis	7.39e-06	4.84e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CAV1—atherosclerosis	7.33e-06	4.8e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—APOA1—atherosclerosis	7.31e-06	4.79e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—HMOX1—atherosclerosis	7.28e-06	4.77e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CD36—atherosclerosis	7.26e-06	4.76e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—APOB—atherosclerosis	7.14e-06	4.68e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS2—atherosclerosis	7.07e-06	4.63e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—APOB—atherosclerosis	6.97e-06	4.57e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTM1—atherosclerosis	6.95e-06	4.55e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—MTHFR—atherosclerosis	6.88e-06	4.51e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.85e-06	4.49e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—LPL—atherosclerosis	6.82e-06	4.47e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HMOX1—atherosclerosis	6.8e-06	4.45e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTM1—atherosclerosis	6.78e-06	4.44e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ABCA1—atherosclerosis	6.77e-06	4.44e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NAMPT—atherosclerosis	6.76e-06	4.43e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPARA—atherosclerosis	6.75e-06	4.42e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—LIPC—atherosclerosis	6.72e-06	4.4e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOC3—atherosclerosis	6.68e-06	4.38e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CG—atherosclerosis	6.67e-06	4.37e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—LPL—atherosclerosis	6.66e-06	4.36e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GPX1—atherosclerosis	6.65e-06	4.36e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—LDLR—atherosclerosis	6.64e-06	4.35e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AGT—atherosclerosis	6.54e-06	4.28e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—APOB—atherosclerosis	6.51e-06	4.27e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GPX1—atherosclerosis	6.49e-06	4.25e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CETP—atherosclerosis	6.48e-06	4.25e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CD36—atherosclerosis	6.48e-06	4.25e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPARG—atherosclerosis	6.44e-06	4.22e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—APOE—atherosclerosis	6.4e-06	4.2e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CAV1—atherosclerosis	6.35e-06	4.16e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTM1—atherosclerosis	6.33e-06	4.15e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—APOA1—atherosclerosis	6.33e-06	4.15e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CD36—atherosclerosis	6.32e-06	4.14e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—INS—atherosclerosis	6.32e-06	4.14e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—LPL—atherosclerosis	6.22e-06	4.07e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.21e-06	4.07e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—MTHFR—atherosclerosis	6.14e-06	4.02e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GPX1—atherosclerosis	6.07e-06	3.97e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPARA—atherosclerosis	6.02e-06	3.95e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—MTHFR—atherosclerosis	5.99e-06	3.93e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CD36—atherosclerosis	5.91e-06	3.87e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPARA—atherosclerosis	5.88e-06	3.85e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.86e-06	3.84e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AGT—atherosclerosis	5.83e-06	3.82e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HMOX1—atherosclerosis	5.81e-06	3.81e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ALB—atherosclerosis	5.79e-06	3.79e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CG—atherosclerosis	5.78e-06	3.79e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—APOE—atherosclerosis	5.72e-06	3.75e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AGT—atherosclerosis	5.69e-06	3.73e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CAV1—atherosclerosis	5.66e-06	3.71e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—APOA1—atherosclerosis	5.65e-06	3.7e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—MTHFR—atherosclerosis	5.6e-06	3.67e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—APOE—atherosclerosis	5.58e-06	3.66e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPARG—atherosclerosis	5.58e-06	3.65e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOB—atherosclerosis	5.56e-06	3.65e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—NOS3—atherosclerosis	5.54e-06	3.63e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CAV1—atherosclerosis	5.53e-06	3.62e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—APOA1—atherosclerosis	5.52e-06	3.61e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPARA—atherosclerosis	5.49e-06	3.6e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—INS—atherosclerosis	5.47e-06	3.58e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTM1—atherosclerosis	5.41e-06	3.55e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AGT—atherosclerosis	5.32e-06	3.49e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—LPL—atherosclerosis	5.31e-06	3.48e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.23e-06	3.42e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—APOE—atherosclerosis	5.21e-06	3.41e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GPX1—atherosclerosis	5.18e-06	3.4e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CAV1—atherosclerosis	5.16e-06	3.38e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CG—atherosclerosis	5.16e-06	3.38e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—APOA1—atherosclerosis	5.15e-06	3.38e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS2—atherosclerosis	5.07e-06	3.32e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CD36—atherosclerosis	5.05e-06	3.31e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CG—atherosclerosis	5.04e-06	3.3e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALB—atherosclerosis	5.02e-06	3.29e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPARG—atherosclerosis	4.98e-06	3.26e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—INS—atherosclerosis	4.88e-06	3.2e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPARG—atherosclerosis	4.86e-06	3.18e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NOS3—atherosclerosis	4.8e-06	3.14e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—MTHFR—atherosclerosis	4.78e-06	3.13e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—INS—atherosclerosis	4.77e-06	3.12e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CG—atherosclerosis	4.7e-06	3.08e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPARA—atherosclerosis	4.69e-06	3.08e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AGT—atherosclerosis	4.55e-06	2.98e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPARG—atherosclerosis	4.54e-06	2.97e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.48e-06	2.94e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALB—atherosclerosis	4.48e-06	2.93e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOE—atherosclerosis	4.45e-06	2.92e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—INS—atherosclerosis	4.45e-06	2.92e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CAV1—atherosclerosis	4.41e-06	2.89e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOA1—atherosclerosis	4.4e-06	2.88e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS2—atherosclerosis	4.39e-06	2.87e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALB—atherosclerosis	4.37e-06	2.86e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOB—atherosclerosis	4.29e-06	2.81e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NOS3—atherosclerosis	4.28e-06	2.81e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NOS3—atherosclerosis	4.18e-06	2.74e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.18e-06	2.74e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—LPL—atherosclerosis	4.1e-06	2.69e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALB—atherosclerosis	4.08e-06	2.67e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.02e-06	2.63e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GPX1—atherosclerosis	4e-06	2.62e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS2—atherosclerosis	3.92e-06	2.57e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NOS3—atherosclerosis	3.9e-06	2.56e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CD36—atherosclerosis	3.9e-06	2.55e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPARG—atherosclerosis	3.88e-06	2.54e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS2—atherosclerosis	3.82e-06	2.5e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—INS—atherosclerosis	3.8e-06	2.49e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.69e-06	2.42e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPARA—atherosclerosis	3.62e-06	2.37e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.57e-06	2.34e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—AKT1—atherosclerosis	3.55e-06	2.33e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AGT—atherosclerosis	3.51e-06	2.3e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALB—atherosclerosis	3.49e-06	2.29e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOE—atherosclerosis	3.44e-06	2.25e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CAV1—atherosclerosis	3.41e-06	2.23e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOA1—atherosclerosis	3.4e-06	2.23e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NOS3—atherosclerosis	3.34e-06	2.19e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.1e-06	2.03e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.05e-06	2e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPARG—atherosclerosis	2.99e-06	1.96e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—INS—atherosclerosis	2.94e-06	1.92e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALB—atherosclerosis	2.69e-06	1.76e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NOS3—atherosclerosis	2.58e-06	1.69e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AKT1—atherosclerosis	2.55e-06	1.67e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.36e-06	1.54e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AKT1—atherosclerosis	2.21e-06	1.44e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AKT1—atherosclerosis	1.97e-06	1.29e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AKT1—atherosclerosis	1.92e-06	1.26e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AKT1—atherosclerosis	1.79e-06	1.18e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AKT1—atherosclerosis	1.53e-06	1e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AKT1—atherosclerosis	1.18e-06	7.76e-06	CbGpPWpGaD
